SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000929638-10-000023
Filing Date
2010-01-13
Accepted
2010-01-13 16:15:23
Documents
1
Group Members
BAM CAPITAL, LLCBAM MANAGEMENT, LLCBAM OPPORTUNITY FUND SPV, LLCHAL MINTZROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 antigenics_sch13ga2.htm SC 13G/A 206846
  Complete submission text file 0000929638-10-000023.txt   208923
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Subject) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60419 | Film No.: 10525288
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Opportunity Fund, L.P. (Filed by) CIK: 0001433768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A